DLD Asset Management’s iTeos Therapeutics ITOS Stock Holding History

DLD Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-576,655	Closed	-$5.75M	–	384
2025 Q2	$5.75M	Buy	+576,655	New	+$4.65M	0.48%	47

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

DLD Asset Management's ITOS Position: Q3 2025 in Review

DLD Asset Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 576,655 shares — an estimated $5.75M sold.

DLD Asset Management first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $5.75M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

DLD Asset Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
DLD Asset Management sold 576,655 iTeos Therapeutics shares in Q3 2025, an estimated $5.75M.
DLD Asset Management first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
DLD Asset Management's iTeos Therapeutics position peaked at $5.75M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on DLD Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.